- List of Appointed Distributors Under Special Conditions of Type A License
- Guideline for the Management of Medicine Donations
- Ministry of Health Medicines Formulary (MOHMF)
- Guidelines for Pharmacists on the Application for Permission to Sell Compounded Preparations at Community Pharmacy Premises and Notification of Compounded Preparations
- Medicine Prices Monitoring Survey In Malaysia 2022
Related FAQ
Contact Us
Lot 36,
Jalan Universiti (Jalan Prof Diraja Ungku Aziz),
46200 Petaling Jaya, Selangor.
[ Location map ]
Phone: 603-7841 3200
Fax: 603-7968 2222
You are here
Malaysian National Medicines Policy (MNMP) Fourth Term
Malaysian National Medicines Policy Fourth Term (2022-2026) is published as a revised version and strengthened in line with the changing times and country's health needs to the third edition. Components from the third term remained in the fourth term. The five (5) components in the fourth term are as follows:
- Governance in Medicines
- Quality, Safety and Efficacy of Medicines
- Access to Medicines
- Quality Use of Medicines
- Partnership and Collaboration for the Healthcare Industry
The MNMP Second Term started its revision in year 2022. A revised document was produced and endorsed by the MNMP Steering Committee in April 2023. The document was published as ‘Malaysian National Medicines Policy Fourth Term’ which contains policy statement, issues and challenges as well as Master Plan of Action with planned strategies and initiatives.
Attachment | Size |
---|---|
![]() | 10.91 MB |